Ferozsons Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Ferozsons Laboratories has a total shareholder equity of PKR8.8B and total debt of PKR4.2B, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are PKR18.3B and PKR9.5B respectively. Ferozsons Laboratories's EBIT is PKR1.4B making its interest coverage ratio 5.5. It has cash and short-term investments of PKR1.3B.
Key information
47.9%
Debt to equity ratio
PK₨4.20b
Debt
| Interest coverage ratio | 5.5x |
| Cash | PK₨1.34b |
| Equity | PK₨8.76b |
| Total liabilities | PK₨9.53b |
| Total assets | PK₨18.29b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: FEROZ's short term assets (PKR10.2B) exceed its short term liabilities (PKR6.9B).
Long Term Liabilities: FEROZ's short term assets (PKR10.2B) exceed its long term liabilities (PKR2.7B).
Debt to Equity History and Analysis
Debt Level: FEROZ's net debt to equity ratio (32.6%) is considered satisfactory.
Reducing Debt: FEROZ's debt to equity ratio has increased from 6% to 47.9% over the past 5 years.
Debt Coverage: FEROZ's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: FEROZ's interest payments on its debt are well covered by EBIT (5.5x coverage).